Hematology Flashcards
Describe prekallikrein or Fletcher factor deficiency in horses.
- Inherited disorder of Miniature and Belgian horses.- Required for activation of factor XII in intrinsic pathway, therefore important in thrombosis.- Asymptomatic but bleed in response to trauma.- Prolonged APTT, normal PT (intrinsic pathway only).
Describe von Willenbrand factor deficiency in horses.
- vWBF is required for platelet adhesion.- Reported in one QH filly with haemorrhage from mucosal surfaces post-trauma.- Prolonged APTT, normal PT (intrinsic pathway only).
Describe the pathophysiology of Glanzmann Thrombasthenia.
- Inherited platelet defect caused by change in the platelet glycoprotein IIb-IIIa complex (integrin alpha-2B-beta-3), the receptor that binds fibrinogen and mediates platelet aggregation.- Reported in 6 horses of different breeds, all only had abnormality of alpha-2B subunit.
List the clinical signs and diagnostic test findings in horses with Glanzmann Thrombasthenia.
- Intermittent epistaxis.- Petechial and ecchymotic haemorrhages in the nasopharynx.- Prolonged gingival bleeding time, prolonged clot retraction, impaired platelet aggregation in response to agonists. - May see a mild anaemia secondary to blood loss.- Normal PT, APTT, platelet count.
Define vasculitis.
Pathologic process involving inflammation and necrosis of blood vessel walls. Occurs secondary to primary toxic, infectious or neoplastic disease processes.
List aetiologic agents of vasculitis in horses.
- Equine Viral Arteritis virus.- Purpura Haemorrhagica (most often secondary to Strep equi ss equi infection).- Equine Infectious Anaemia virus.- Equine Granulocytic Ehrlichiosis (Anaplasma phagocytophylum infection).
List clinical manifestations of vasculitis in horses.
- Skin and mucous membranes most commonly affected.- Well-demarcated areas of dermal or s/c oedema that may progress to skin infarction, necrosis and exudation.- Hyperaemia, petechial/ecchymotic haemorrhages, ulceration of mucous membranes.- Secondary cellulitis, thrombophlebitis, laminitis, pneumonia reported.- May occur as primary problem in any organ –> lameness, renal dz, colic, ataxia, dyspnoea.
Describe diagnostic test findings in cases of vasculitis in horses.
- Skin histo: neutrophilic infiltration of venules in the dermis and s/c tissue with nuclear debris in and around vessels and fibrinoid necrosis.- CBC/chem: may be WNL or may see anaemia, neutrophilia, hyperglobulinaemia, hyperfibrinogenaemia, normal platelet count, inc CK, inc creatinine.
Describe the pathogenesis of vasculitis in horses.
Immunologic mechanism suspected e.g. Ag-Ab deposition in vessel walls w subsequent complement activation and chemoattractant prod –> neut/macro release proteolytic enzymes –> vessel wall necrosis –> haemorrhage, oedema and infarction of tissues.
Describe the infectious agents which have been implicated as aetiologic agents in Purpura Haemorrhagica (PH) in horses.
- Strep equi ss equi.- Strep equi ss zooepidemicus.- Rhodococcus equi.- Corynebacterium pseudotuberculosis.- Strep equi ss equi vaccination.
List clinical signs of PH in horses.
- Most often in young to middle aged horses.- Develops acutely within weeks of resp infection.- Well demarcated s/c oedema of the limbs.- Anorexia.- Lethargy.- Fever.- Tacchycardia.- Haemorrhages on MMs.- +/- reluctance to move, colic, epistaxis.
List clinicopathologic findings in cases of PH in horses.
- Anaemia.- Neutrophilia.- Hyperglobulinaemia.- Hyperfibrinogenaemia.- Inc CK and AST.- Rarely thrombocytopaenia.
Describe typical histopathologic findings in skin biopsies of horses with PH.
- Diagnostic finding: acute leukocytoclastic or non-leukocystoclastic vasculitis with vessel necrosis.- Dermal and s/c haemorrhage, protein rich oedema, dermal infarction, arteries infiltrated by neutrophils +/- hyaline thrombi.
Describe the pathophysiology of PH in horses.
- Type III hypersensitivity reaction.- Strep equi: primarily IgM or IgA to Strep M protein; Ag-Ab complexes lodge s/c vessels or throughout the body.- May see infarcts in kidneys, GI walls, skeletal muscle, spleen in addition to skin lesions.
Outline treatment and prognosis of PH in horses.
- Address primary cause e.g. Strep –> penicillin at least 2wk.- Suppress immune response: prolonged corticosteroid therapy.- Hydrotherapy, limb bandaging, walking.- +/- IVFT and nutritional support.- Prognosis fair with early and aggressive therapy.- Potential complications: skin sloughing, laminitis, cellulitis, pneumonia, diarrhoea.
Describe the Equine Arteritis Virus.
- Order: Nidovirales.- Family: Arterivirdae.- Genus arterivirus.- Enveloped RNA virus.
How is the EAV transmitted between horses?
- Maintained in accessory organs of the male repro tract in stallions (ampulla, vas deferens).- Transmitted in fresh or frozen semen from asymptomatic carriers via natural service or AI.- Aerosol from respiratory, urinary or repro tract secretions from acutely infected individuals.- Fomites.
List the clinical signs of EAV infection.
- CSx dev 1-10d post-infection.- Pyrexia, lethargy, anorexia.- Oedema: limbs, periorbital, supraorbital, vetral, mammary gland, scrotal.- Stiffness.- Rhinorrhea.- Epiphora.- Conjunctivitis.- Rhinitis.- Abortion.
Describe the pathophysiology of EAV infection.
- Virus rapidly localised in LNs and macrophages –> various tissues –> localised in vessels in endothelium, medial myocytes, pericytes.- Causes vasculitis with fibroid necrosis of tunica media, vascular and perivascular lymphocytic infiltration, loss of endothelium, dev of fibrinocellular thrombi.
Outline methods for diagnosis of EAV.
- Serology: >4x inc 3wk apart.- Virus isolation or PCR on sperm, resp secretions, aborted foetus, placenta.
Outline vaccination requirements for EAV.
- Must submit serum to the USDA prior to vacc to prove seronegative status, as serology does not distinguish between vaccination and natural exposure.- MLV vaccine; isolate post-vacc in case of shedding.
What is the causative agent of Equine Granulocytic Erhlichiosis (EGE)?
- Anaplasma phagocytophilum.- Formerly known as Erhlichia equi.- Gram negative rickettsial bacteria that have a tropisms for neutrophils and eosinophils in horses.
Describe the epidemiology of EGE.
- Reported in USA, Canada, Israel, Europe.- Most cases Autumn to Spring.- No latent/carrier state in horses.- Vectors: Ixodes pacificus and I. scapularis (USA) or I. ricinus (Europe).- Potential reservoir hosts: mice, chipmunks, deer, wood rats, cervids, lizards, birds.
The pathogenesis of EGE is unkown as this time. Describe the proposed pathogenesis of EGE.
- Tick bites horse.- A. phagocytophilum enters blood or lymph stream then infects and replicates in neutrophils and eosinophils.- Cytolysis, inflammation, cell sequestration/destruction/ consumption –> pancytopaenia.- Both CM and humoral IR develops with immunity persisting >2y.
List clinical signs of EGE.
- Reluctance to move.- Fever.- Tachycardia.- Lethargy.- Decreased appetite.- Limb oedema.- Petecchiation.- Icterus.- Weakness.- Ataxia.- Recumbency.- Dz is self-limiting and non-fatal so long as secondary complications do no occur e.g. bacterial, viral or fungal infections.
Outline diagnosis of EGE.
- CBC: anaemia, granulocytopaenia, lymphocytopaenia, thrombocytopaenia.- Blood smear: stain w Wrights stain –> org turns blue; min 3 morulae (granular aggregates) in cytoplasm.- PCR is buffy coat.- Serum IFA titre: >4x inc in paired titres.
Describe necropsy findings in horses that have died from EGE.
- Petechiae and ecchymoses of the s/c tissues.- Oedema of the ventrum, limbs, prepuce.- Proliferative and necrotising vasculitis, thrombosis and perivascular cuffing in the s/c, fascia, kidneys, heart, brain, lung, ovaries, testes.
Outline treatment and prevention of EGE.
- Oxytet/doxycycline for 5-7d –> rapid response.- May be self-limitng if un-tx and resolve in 2-3wk.- Px excellent if no secondary complications.- Prevention: tick control.
Define thrombocytopaenia in the horse.
- Platelet count
List clinical signs of thrombocytopaenia in the horse.
- Multiple sites of small vessel bleeding –> petechial/ ecchymotic haemorrhage on MMs, nictitans, sclera.-
Outline treatment of thrombocytopaenia causing life-threatening haemorrhage in horses.
- Administration of fresh blood or PRP used immediately.- NB do not store blood in glass –> platelet adhesion.
List causes of thrombocytopaenia in large animals.
- Shortened lifespan most common in LA: DIC, vasculitis.- Hypoplastic anaemia w thrombocytopaenia.- Myelophthisic dz (replacement of BM by neoplastic or inflammatory cells): reported but rare.- IMTP: primary (idiopathic) or secondary (drug admin, infection, neoplasia, other immunologic disorders); reported in horses secondary to EIA, lymphoma, IMHA.- Alloimmune thrombocytopaenia of neonates: horse and mule foals and piglets; severe dec platelets, inc bleeding time, n PT/APTT; definitive dx: inc quantities of platelet-assoc IgG or C3 or anti-platelet activity.
Define Disseminated Intravascular Coagulation (DIC).
Secondary disease characterised by widespread fibrin deposition in the microcirculation (–> ischaemia) and development of haemorrhagic diathesis caused by the consumption of pro-coagulants and hyperactivity of fibrinolysis.
List clinical signs of DIC in large animals.
- Can vary widely from diffuse thrombosis –> ischaemic organ failure to haemorrhagic diathesis.- Overt bleeding rare in cattle and horses.- MODS more common in cattle and horses.- Renal involvement common.- Colic can occur from GI microthrombi.- Pulmonary involvement –> tachypnoea, dyspnoea.- Cerebral signs uncommon in large animals.- Horses: laminitis, thrombosis of peripheral vv.- Horses may get chronic compensated form –> chronic low-grade pro-coagulant stimulus.
Outline results of coagulation tests in large animals with DIC.
- Results vary; as Dz progresses see following results.- Prolonged TT, PT, APTT.- Inc D-dimers and FDPs.- Fibrinogen and platelet count: WNL or sl dec.
Describe the pathophysiology of DIC in large animals.
i) Generation of excessive pro-coagulant factors in the blood or contact of blood w abnormal surfaces –> excessive thrombin prod –> ischaemia e.g. LPS stimulates mono/macro –> prod of pro-coag factors: platelet activating factor, tissue factor, Pgs, ILs, TNF.ii) Counter-balance fibrinolytic system is activated; liver and spleen overwhelmed and unable to remove FDPs and activated clotting factors from circulation.
Outline treatment of DIC in large animals.
- Treat underlying disease e.g. Sx for strangulated SI, ABs for sepsis.- Combat shock and maintain tissue perfusion: IVFT, flunixin; +/- plasma.- +/- LMWH (controversial).
List the aetiologic agents known to cause Piroplasmosis in horses.
- Babesia caballi - intra-erythrocytic parasite similar to B. bigemina, pear-shaped, forms acute-angled pairs.- Theileria equi (more pathogenic) - parasite with lymphocytic and erythrocytic stages; intraerythrocyte parasite divides into four cells to form a Maltese cross.
Describe the epidemiology of Equine Piroplasmosis.
- Widely distributed through tropics and subtropics; less in temperate areas.- Both parasites transmitted by ticks of the genera Dermancentor, Hyalomma and Rhipicephalus.- Once infected horses remain chronic carriers.- T. equi can be transmitted transplacentally.- Incubation period 5-28d.
List clinical signs of Equine Piroplasmosis.
- Fever, depression, anorexia.- Haemolytic anaemia and haemoglobinuria.- Jaundice.- In-coordination.- Lacrimation.- Mucoid nasal discharge.- Swelling of the eyelids.- Frequent lying down.- Death.
Describe diagnostic test findings in horses with Piroplasmosis.
- CBC: anaemia, parasite in RBCs stained w Giesma stain; T equi may see moncytosis and eosinopaenia.- Haemoglobinuria (may be absent w B. caballi).- Serum: cELISA (official test OIE/USDA).- Whole blood: PCR.
Outline treatment and prognosis for horses with Equine Piroplasmosis.
- Imidocarb; T. equi more refractory to tx than B. caballi.- Good Px if Dx and Tx early.- Higher doses of imidocarb can cause transient colic in horses.- Control of tick infestations.
What bacteria is responsible for most Leptospirosis infections in horses in North America? What is its most common maintenance host? What serovar is considered by some to be the host-adapted species in horses?
- Leptospira pomona kennewick.- Skunk is most common maintenance host.- L. bratislava is considered by some to be a host-adapted spp in horses while others think it is pathogenic.
What disease can be caused by Leptospirosis in horses?
- Uveitis and immune-mediated keratitis.- Placentitis.- Abortion.- Stillbirth.- Renal disease: tubulointerstitial nephritis, pyuria, rarely ARF.- Haemolytic anaemia.
List clinical signs of Leptospirosis in horses.
- Fever.- Anaemia.- Jaundice.- Abortions during late-term gestation.- Signs of renal or ocular dz.
Outline diagnosis of Leptospirosis in horses.
- Serology: microscopic agglutination titre; 1:6400 significant or rising titres over 2-3wk period.- Infected tissues: IFAT.- PCR.- Histology.- Bacterial culture.
Outline treatment options for Leptospirosis in horses.
- ABs: ampicillin, amoxicillin, penicillin, oxytetracycline, doxycycline.- Anti-inflammatories if ERU or IMMK.
Outline methods for prevention of Leptospirosis in horses.
- Control exposure to shedding hosts, infected animals and contaminated fomites.- Infected horses can shed in urine for up to 14wks.- Isolate pregnant mares from other horses.- In endemic areas isolate horses w titres of 1:6400 or higher.- Clean and disinfect contaminated areas.- Vaccination on farms w endemic abortions or ERU.- Attempts to decrease shedding w ABs not successful.
Describe the Equine Infectious Anaemia (EIA) virus.
- Family: Retroviridae.- Genus: Lentivirus.- RNA virus.- Lentiviruses are integrated into the host’s genome and therefore infection is lifelong.
What tests for EIA are approved by the USDA?
- The Coggins test: agar-gel immunodiffusion (AGID).- 4 ELISAs: detect Ab directed at the transmembrane glycoprotein (gp45) and/or the p26 Ag.- No test based on detection of viral nucleic acid are USDA-approved.
Describe clinical signs of EIA.
- Acute phase:- High fever.- Thrombocytopaenia.- Malaise.- +/- petechial or ecchymotic haemorrhages on MMs.- May go in to DIC and die.- Rarely leukoencephalitis and enterocolitis.2. Chronic phase:- Similar signs as above interspersed with periods of clinical quiescence due to waves of viraemia.- Periods of stress may precipitate clinical dz.- +/- weight loss, dependent oedema, ill-thrift, anaemia.3. Inapparent phase:- Occurs once viraemia is immunologically contained.- No Csx –> inapparent carrier.
Describe the pathophysiology of EIA.
- Lentiviruses use an integrated DNA intermediate to usurp host cells, replicate its genome, make viral proteins and assemble proteins into virions that bud from the cell.- EIAV can generate several viral variants that differ genetically from previous ones –> escape from neutralising AB and cytotoxic T cell responses and thwarts attempts to develop vaccines.- EIAV can replicate in monocytes, dendritic cells. tissue macrophages and endothelial cells (may –> endothelial damage and subsequent thrombosis/vasculitis).
Describe clinicopathologic findings in horses with EIA.
- Anaemia due to intra- and extra-vascular haemolysis and BM supression.- Thrombocytopaenia and hypofunctional platelets.- Hyperglobulinaemia, hypoalbuminaemia, polyclonal B cell proliferation.
Describe necropsy findings in horses that have died from EIA.
- Splenomegaly.- Hepatomegaly.- Lymphadenitis.- Pronounced hepatic lobular architecture.- Echymoses of mucosa and viscera.- Dependent s/c oedema.- Mononuclear cell infiltrate in periportal regions of the liver, spleen, LNs, meninges and lungs.- Haemosiderophages in spleen, LNs, liver, BM.- Immune-med glomerulonephritis.